Nitric oxide donor S-Nitroso-N-acetyl penicillamine for hepatic stellate cells to restore quiescence

Abstract

Liver fibrosis is a hepatic scar repair response associated with a wide range of liver injuries, which is mediated by an imbalance between extracellular matrix (ECM) synthesis and degradation, leading to massive ECM deposition and disruption of normal liver architecture. Hepatic stellate cells (HSCs) are the main source of ECM during liver fibrosis and are the first identified cell subpopulation associated with liver fibrosis formation. Various current studies on the mechanism and treatment of liver fibrosis require resting-state HSCs as study subjects. However, spontaneous activation of primary HSCs occurs after 2–3 days of culture after isolation, and it is common that HSCs cell lines gradually differentiate into fibroblasts with culture time. This study provides an induction medium for quiescent HSCs-containing all-trans retinoic acid, sodium oleate, and S-nitroso-N-acetyl penicillamine (SNAP)-and an induction method. The induction method not only maintains the HSCs cell line in a quiescent state but also restores the activated HSCs to a quiescent state. The method has a good induction effect, short induction time, and convenient operation, which is worth being popularized and used in a wide range of laboratories.

Keywords

hepatic stellate cells / lipid droplets / mitochondria / Oil Red O staining

References

[1] FriedmanSL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008; 88(1):125-172.

[2] ZhaoL.-N, GandhiCR, GaoZ.-H. Involvement of cytosolic phospholipase A2 alpha signalling pathway in spontaneous and transforming growth factor-beta-induced activation of rat hepatic stellate cells. Liver Int. 2011; 31(10):1565-1573.

[3] El-LakkanyNM, El-Maadawy WH, Seif El-DinSH, et al. Rosmarinic acid attenuates hepatic fibrogenesis via suppression of hepatic stellate cell activation/proliferation and induction of apoptosis. Asian Pac J Tropical Med. 2017; 10(5):444-453.

[4] FernandoM, van Mourik I, WassmerE, KellyD. Wilson disease in children and adolescents. Arch Dis Child. 2020; 105(5):499-505.

[5] HederaP. Wilson’s disease: a master of disguise. Parkinsonism Relat Disorders. 2019; 59:140-145.

[6] LiY.-P, ZhangT, ZhangJ.-H, et al. Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis. Biomaterials. 2023; 301:122232.

[7] CaoR, CaoC, HuX.-J, et al. Kaempferol attenuates carbon tetrachloride (CCl₄)-induced hepatic fibrosis by promoting ASIC1a degradation and suppression of the ASIC1a-mediated ERS. Phytomedicine. 2023; 121:155125.

[8] Ben-MosheS, VegT, MancoR, et al. The spatiotemporal program of zonal liver regeneration following acute injury. Cell Stem Cell. 2022; 29(6):973-989.e10.

[9] WangS.-S, TangXT, LinM.-H, et al. Perivenous stellate cells are the main source of myofibroblasts and cancer-associated fibroblasts formed after chronic liver injuries. Hepatology. 2021; 74(3):1578-1594.

[10] PayenVL, Lavergne A, AlevraSN, et al. Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity. JHEP Rep. 2021; 3(3):100278.

[11] Cardoso-LezamaI, Ramos-Tovar E, Arellanes-RobledoJ, et al. Serum α-SMA is a potential noninvasive biomarker of liver fibrosis. Toxicol Mech Methods. 2024; 34(1):13-19.

[12] ZhaoH.-Z, ZhuH, ZhangY, et al. Lymphocyte-specific protein tyrosine kinase contributes to spontaneous regression of liver fibrosis mayby interacting with suppressor of cytokine signaling 1. Inflammation. 2023; 46(5):1653-1669.

[13] LeleS, LeeSD, SarkarD, Levy MF. Purification and isolation of hepatic stellate cells. Methods Mol Biol. 2022; 2455:93-101.

[14] QiJ, YanX.-Q, LiL.-Q, Qiu K.-X, HuangW.-Z, ZhouZ.-X. CXCL5 promotes lipotoxicity of hepatocytes through upregulating NLRP3/Caspase-1/IL-1β signaling in Kupffer cells and exacerbates nonalcoholic steatohepatitis in mice. Int Immunopharm. 2023; 123:110752.

[15] GäberleinK, Schröder SK, NandaI, et al. Genetic characterization of rat hepatic stellate cell line PAV-1. Cells. 2023; 12(12):1603.

[16] XuL, HuiAY, AlbanisE, et al. Human hepatic stellate cell lines, LX-1 and LX-2:new tools for analysis of hepatic fibrosis. Gut. 2005; 54(1):142-151.

[17] DuJ.-B, ZhaoL, KangQ, He Y, BiY. An optimized method for Oil Red O staining with the salicylic acid ethanol solution. Adipocyte. 2023; 12(1):2179334.

[18] JunI, KimBR, ParkSY, et al. Interleukin-4 stimulates lipogenesis in meibocytes by activating the STAT6/PPARγ signaling pathway. Ocul Surf. 2020; 18(4):575-582.

[19] JensenEC. Quantitative analysis of histological staining and fluorescence using ImageJ. Anat Rec. 2013; 296(3):378-381.

[20] JophlinLL, Koutalos Y, ChenC.-H, ShahV, RockeyDC. Hepatic stellate cells retain retinoid-laden lipid droplets after cellular transdifferentiation into activated myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 2018; 315(5): G713-G721.

[21] Bobowski-GerardM, Zummo FP, StaelsB, LefebvreP, Eeckhoute J. Retinoids issued from hepatic stellate cell lipid droplet loss as potential signaling molecules orchestrating a multicellular liver injury response. Cells. 2018; 7(9):137.

[22] CogliatiB, Yashaswini CN, WangS, SiaD, Friedman SL. Friend or foe? The elusive role of hepatic stellate cells in liver cancer. Nat Rev Gastroenterol Hepatol. 2023; 20(10):647-661.

[23] JainI, Brougham-Cook A, UnderhillGH. Effect of distinct ECM microenvironments on the genome-wide chromatin accessibility and gene expression responses of hepatic stellate cells. Acta Biomater. 2023; 167:278-292.

[24] UeharaK, Santoleri D, WhitlockAEG, TitchenellPM. Insulin regulation of hepatic lipid homeostasis. Compr Physiol. 2023; 13(3):4785-4809.

[25] MobasheriL, AhadiM, Beheshti NamdarA, et al. Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicals. Biomed Pharmacother. 2023; 167:115502.

[26] GuJ.-Y, SunJ.-F, TianK, et al. Reversal of hepatic fibrosis by the co-delivery of drug and ribonucleoprotein-based genome editor. Biomaterials. 2023; 298:122133.

[27] TauraN, Ichikawa T, HamasakiK, et al. Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients. Am J Gastroenterol. 2006; 101(12):2752-2759.

[28] NicoteraP, Bernassola F, MelinoG. Nitric oxide (NO), a signaling molecule with a killer soul. Cell Death Differ. 1999; 6(10):931-933.

[29] FörstermannU, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012; 33(7):829-837.

[30] LindM, HayesA, CaprndaM, et al. Inducible nitric oxide synthase: good or bad? Biomed Pharmacother. 2017; 93:370-375.

[31] RuartM, Chavarria L, CampreciósG, et al. Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury. J Hepatol. 2019; 70(3):458-469.

[32] HwangJH, HeoW, ParkJI, et al. Endothelial TAZ inhibits capillarization of liver sinusoidal endothelium and damage-induced liver fibrosis via nitric oxide production. Theranostics. 2023; 13(12):4182-4196.

[33] IwakiriY. Nitric oxide in liver fibrosis: the role of inducible nitric oxide synthase. Clin Mol Hepatol. 2015; 21(4):319-325.

[34] AliG, MohsinS, KhanM, et al. Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis. J Transl Med. 2012; 10(1):75.

[35] LautnerG, Meyerhoff ME, SchwendemanSP. Biodegradable poly(lactic-co-glycolic acid) microspheres loaded with S-nitroso-N-acetyl-D-penicillamine for controlled nitric oxide delivery. J Contr Release. 2016; 225:133-139.

[36] HopkinsSP, FrostMC. S-Nitroso-N-Acetyl-D-Penicillamine modified hyperbranched polyamidoamine for high-capacity nitric oxide storage and release. Bioengineering (Basel). 2020; 7(1):9.

[37] MigitaK, MaedaY, AbiruS, et al. Peroxynitrite-mediated matrix metalloproteinase-2 activation in human hepatic stellate cells. FEBS Lett. 2005; 579(14):3119-3125.

[38] FailliP, DeFRANCO RM, CaligiuriA, et al. Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. Gastroenterology. 2000; 119(2):479-492.

RIGHTS & PERMISSIONS

2024 The Author(s). Pediatric Discovery published by John Wiley & Sons Australia, Ltd on behalf of Children’s Hospital of Chongqing Medical University.